[
  {
    "ts": null,
    "headline": "Regeneron (REGN): Revisiting Valuation After Recent 16% Share Price Rally",
    "summary": "Regeneron Pharmaceuticals (REGN) shares have been in focus recently, attracting investor interest thanks to their steady revenue and net income growth over the past year. The stock has gained 16% in the past month alone. See our latest analysis for Regeneron Pharmaceuticals. After a challenging stretch, Regeneron’s recent 1-month share price return of nearly 16% suggests that momentum may finally be turning upward, despite the fact that the 1-year total shareholder return is still down almost...",
    "url": "https://finnhub.io/api/news?id=57c32112844562a735c6f6e9cbe18783361a91680a2e5c436b1fd46aa0f9c363",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762881091,
      "headline": "Regeneron (REGN): Revisiting Valuation After Recent 16% Share Price Rally",
      "id": 137449048,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Regeneron Pharmaceuticals (REGN) shares have been in focus recently, attracting investor interest thanks to their steady revenue and net income growth over the past year. The stock has gained 16% in the past month alone. See our latest analysis for Regeneron Pharmaceuticals. After a challenging stretch, Regeneron’s recent 1-month share price return of nearly 16% suggests that momentum may finally be turning upward, despite the fact that the 1-year total shareholder return is still down almost...",
      "url": "https://finnhub.io/api/news?id=57c32112844562a735c6f6e9cbe18783361a91680a2e5c436b1fd46aa0f9c363"
    }
  }
]